empty

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol) to include reducing the risk of CV events in patients with CHD and a history of acute coronary syndrome. Ezetimibe should be added to, or initiated with, a statin.

Recommended

Clinical review: Antihypertensive medication

NICE recommends Tremfya




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.